Treatment of Heterogeneous Emphysema Using the Spiration IBV Valves
dc.contributor.author | Springmeyer S.C. | |
dc.contributor.author | Bolliger C.T. | |
dc.contributor.author | Waddell T.K. | |
dc.contributor.author | Gonzalez X. | |
dc.contributor.author | Wood D.E. | |
dc.date.accessioned | 2011-05-15T16:18:13Z | |
dc.date.available | 2011-05-15T16:18:13Z | |
dc.date.issued | 2009 | |
dc.description.abstract | Ninety-eight emphysema patients were treated at 13 international sites during a 3-year series of single-arm, open-label studies with the IBV valve and a multi-lobar treatment approach. Fifty six percent of subjects had a clinically meaningful improvement in health-related quality of life, but standard pulmonary function and exercise studies were insensitive effectiveness measures. Quantitative CT analyses of regional lung changes showed lobar volume changes in over 85% of subjects. Lung volume reduction was an uncommon mechanism for a treatment response with bilateral upper lobe treatment. A redirection of inspired air, an interlobar shift to healthier lung tissue, was the most common mechanism for a valve treatment response. © 2009 Elsevier Inc. All rights reserved. | |
dc.description.version | Review | |
dc.identifier.citation | Thoracic Surgery Clinics | |
dc.identifier.citation | 19 | |
dc.identifier.citation | 2 | |
dc.identifier.issn | 15474127 | |
dc.identifier.other | 10.1016/j.thorsurg.2009.02.005 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14560 | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | atelectasis | |
dc.subject | bronchospasm | |
dc.subject | clinical effectiveness | |
dc.subject | clinical trial | |
dc.subject | cohort analysis | |
dc.subject | computer assisted tomography | |
dc.subject | controlled study | |
dc.subject | emphysema | |
dc.subject | exercise | |
dc.subject | female | |
dc.subject | heart arrest | |
dc.subject | heart infarction | |
dc.subject | heterogeneous emphysema | |
dc.subject | hospitalization | |
dc.subject | human | |
dc.subject | inspiratory capacity | |
dc.subject | lung function | |
dc.subject | lung lobe | |
dc.subject | lung parenchyma | |
dc.subject | lung resection | |
dc.subject | lung volume | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | multicenter study | |
dc.subject | open study | |
dc.subject | pneumothorax | |
dc.subject | priority journal | |
dc.subject | prosthesis | |
dc.subject | quality of life | |
dc.subject | quantitative analysis | |
dc.subject | respiratory distress | |
dc.subject | review | |
dc.subject | spiration IBV valve | |
dc.subject | surgical approach | |
dc.subject | thorax pain | |
dc.subject | treatment outcome | |
dc.subject | treatment response | |
dc.subject | Aged | |
dc.subject | Bronchoscopy | |
dc.subject | Cohort Studies | |
dc.subject | Equipment Design | |
dc.subject | Exercise Tolerance | |
dc.subject | Female | |
dc.subject | Forced Expiratory Volume | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Pneumonectomy | |
dc.subject | Pulmonary Emphysema | |
dc.subject | Retrospective Studies | |
dc.subject | Treatment Outcome | |
dc.title | Treatment of Heterogeneous Emphysema Using the Spiration IBV Valves | |
dc.type | Review |